Cargando…

Influence of angiotensin II receptor blocker combination tablet prescription on drug number and cost

OBJECTIVES: Combination therapy using an angiotensin II receptor blocker is expected to promote medication adherence and alleviate economic burden among patients by reducing the number of drugs taken, and thereby to lower associated medical costs. In the present retrospective study, we conducted a s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Teramachi, Hitomi, Takahashi, Tatsuya, Tachi, Tomoya, Noguchi, Yoshihiro, Nagasawa, Hiroyuki, Ino, Yoko, Mizui, Takashi, Goto, Chitoshi, Tsuchiya, Teruo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2014
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4712752/ https://www.ncbi.nlm.nih.gov/pubmed/26770757 http://dx.doi.org/10.1177/2050312114563318

Ejemplares similares

The Impact of Outpatient Chemotherapy-Related Adverse Events on the Quality of Life of Breast Cancer Patients
por: Tachi, Tomoya, et al.
Publicado: (2015)

The impact of side effects from outpatient chemotherapy on presenteeism in breast cancer patients: a prospective analysis
por: Tachi, Tomoya, et al.
Publicado: (2016)

The adoption of generic drugs by a hospital: effects on drug dispensation among community pharmacies
por: Tachi, Tomoya, et al.
Publicado: (2018)

Effects of the number of drugs used on the prevalence of adverse drug reactions in children
por: Sugioka, Mayuko, et al.
Publicado: (2020)

Evaluation of the Direct Costs of Managing Adverse Drug Events in all Ages and of Avoidable Adverse Drug Events in Older Adults in Japan
por: Katsuno, Hayato, et al.
Publicado: (2021)

Renoprotective Effect of Dipeptidyl Peptidase-4 Inhibitors in Patients with Type 2 Diabetes Mellitus
por: Esaki, Hiroki, et al.
Publicado: (2017)

Subset Analysis for Screening Drug–Drug Interaction Signal Using Pharmacovigilance Database
por: Noguchi, Yoshihiro, et al.
Publicado: (2020)

Review of Statistical Methodologies for Detecting Drug–Drug Interactions Using Spontaneous Reporting Systems
por: Noguchi, Yoshihiro, et al.
Publicado: (2019)

The Effect of Quality of Life on Medication Compliance Among Dialysis Patients
por: Nagasawa, Hiroyuki, et al.
Publicado: (2018)

The Relationship Between Dialysis Patients' Quality of Life and Caregivers' Quality of Life
por: Nagasawa, Hiroyuki, et al.
Publicado: (2018)

Impact of pharmacist counseling on reducing instances of adverse events that can affect the quality of life of chemotherapy outpatients with breast Cancer
por: Tanaka, Kazuhide, et al.
Publicado: (2018)

Effect of Dipeptidyl Peptidase-4 Inhibitors vs. Metformin on Major Cardiovascular Events Using Spontaneous Reporting System and Real-World Database Study
por: Noguchi, Yoshihiro, et al.
Publicado: (2022)

Analyses of non-benzodiazepine-induced adverse events and prognosis in elderly patients based on the Japanese adverse drug event report database
por: Noguchi, Yoshihiro, et al.
Publicado: (2018)

Differences in detected safety signals between benzodiazepines and non-benzodiazepine hypnotics: pharmacovigilance study using a spontaneous reporting system
por: Toyoshima, Manabu, et al.
Publicado: (2021)

Improved Detection Criteria for Detecting Drug-Drug Interaction Signals Using the Proportional Reporting Ratio
por: Noguchi, Yoshihiro, et al.
Publicado: (2020)

Signals of gastroesophageal reflux disease caused by incretin-based drugs: a disproportionality analysis using the Japanese adverse drug event report database
por: Noguchi, Yoshihiro, et al.
Publicado: (2018)

Factors Influencing Medicine Use Behavior in Adolescents in Japan Using a Bayesian Network Analysis
por: Sakai, Chihiro, et al.
Publicado: (2019)

Verification of the “Upward Variation in the Reporting Odds Ratio Scores” to Detect the Signals of Drug–Drug Interactions
por: Noguchi, Yoshihiro, et al.
Publicado: (2021)

Angioedema Caused by Drugs That Prevent the Degradation of Vasoactive Peptides: A Pharmacovigilance Database Study
por: Noguchi, Yoshihiro, et al.
Publicado: (2021)

A simple method for exploring adverse drug events in patients with different primary diseases using spontaneous reporting system
por: Noguchi, Yoshihiro, et al.
Publicado: (2018)

A New Search Method Using Association Rule Mining for Drug-Drug Interaction Based on Spontaneous Report System
por: Noguchi, Yoshihiro, et al.
Publicado: (2018)

Changes in the quality of medicines during storage under LED lighting and consideration of countermeasures
por: Yamashita, Shuuji, et al.
Publicado: (2018)

Cost-effectiveness analysis of olanzapine in four-drug antiemetic therapy in Japanese patients treated with highly emetogenic cisplatin-containing chemotherapy
por: Kondo, Yu, et al.
Publicado: (2022)

Rate of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers Use and the Number of COVID-19–Confirmed Cases and Deaths
por: Tereshchenko, Larisa G., et al.
Publicado: (2022)

Prescriptions and Dispensing: Compressed Tablets
Publicado: (1908)

Prescription of renin–angiotensin system blockers and risk of acute kidney injury: a population-based cohort study
por: Mansfield, Kathryn E, et al.
Publicado: (2016)

Calcium channel blockers, angiotensin receptor blockers, and angiotensin-converting enzyme inhibitors: Effectiveness in combination with diuretics or β-blockers for treating hypertension
por: Bisognano, John D, et al.
Publicado: (2007)

Angiotensin receptor blocker add-on therapy in portal hypertension: To use angiotensin receptor blocker or not to use, that is the question
por: Lee, Hyun Woong
Publicado: (2014)

Increase in prescription rate of angiotensin-converting enzyme inhibitors or angiotensin receptor blocker for hospitalized patients with acute myocardial infarction and left ventricular systolic dysfunction
por: Makdisse, MRP, et al.
Publicado: (2007)

Angiotensin receptor blockers and COVID-19
por: Saavedra, Juan M.
Publicado: (2020)

Angiotensin receptor blocker neprilysin inhibitors
por: Usuda, Daisuke, et al.
Publicado: (2021)

Renin-Angiotensin System Blockers and the COVID-19 Pandemic: At Present There Is No Evidence to Abandon Renin-Angiotensin System Blockers
por: Danser, A.H. Jan, et al.
Publicado: (2020)

Premorbid Use of Beta-Blockers or Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Patients with Acute Ischemic Stroke
por: Zeng, Yuanyuan, et al.
Publicado: (2023)

Increasing prescription of renin–angiotensin–aldosterone system blockers associated with improved kidney prognosis in Korean IgA nephropathy patients
por: Park, Sehoon, et al.
Publicado: (2020)

COVID-19, Angiotensin Receptor Blockers, and the Brain
por: Saavedra, Juan M.
Publicado: (2020)

Renin-angiotensin system blockers and COVID-19
por: Vidal-Petiot, Emmanuelle, et al.
Publicado: (2021)

The use of angiotensin receptor blockers in dementia prevention
por: Müller, Jordana de Araujo, et al.
Publicado: (2023)

Influence of analysis conditions for antimicrobial susceptibility test data on susceptibility rates
por: Hatsuda, Yasutoshi, et al.
Publicado: (2020)

The Fetal Safety of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers
por: Moretti, Myla E., et al.
Publicado: (2012)

Effect of angiotensin converting enzyme inhibitors and angiotensin receptor blockers on hemoglobin levels
por: Ajmal, Adnan, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_v22fpgak5pdqm1let1gv7q21ik